Elite Pharmaceuticals, Inc. (ELTP)

OTCMKTS · Delayed Price · Currency is USD

0.6950

+0.0362 (5.49%)

Aug 29, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2005 - 2019
Abbreviated New Drug Applications	84.04M	Log In	Log In	Log In	Log In	Upgrade
Abbreviated New Drug Applications Growth	48.42%	Log In	Log In	Log In	Log In	Upgrade
New Drug Applications	-	Log In	Log In	Log In	Log In	Upgrade
New Drug Applications Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2005 - 2019
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2005 - 2019
United States	84.04M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	48.42%	Log In	Log In	Log In	Log In	Upgrade